Industry News
Pharmaceutical Industry News

Justice Dept. Sues AmerisourceBergen Over Role in Opioid Crisis
Investigators said the pharmaceutical manufacturer, one of the nation’s largest, had knowingly distributed opioids that were later resold illegally.
Congressional Investigation into Alzheimer’s Drug Aduhelm Faults the F.D.A. and Biogen
The report said the F.D.A.’s approval process for Aduhelm was “rife with irregularities” and criticized Biogen for setting an “unjustifiably high price.”
Covid en China: el abrupto aumento de casos impulsa una escasez de medicinas
Hay millones de personas desesperadas por conseguir medicamentos para la fiebre y antivirales como el Paxlovid de Pfizer en un momento en que las infecciones le ganan la carrera al abastecimiento.
The F.D.A. Now Says It Plainly: Morning-After Pills Are Not Abortion Pills
Labels of Plan B One-Step had previously said, without scientific evidence, that the pill might block fertilized eggs from implanting in the womb.
‘Tripledemic’ Forces Pharmacies to Limit Purchases of Children’s Pain Relievers
CVS, Walgreens and Kroger are limiting sales of products like Children’s Tylenol and Motrin as cases of the flu, R.S.V. and Covid-19 spike.
China’s Abrupt Covid Pivot Leaves Many Without Medicines
Millions are desperate to get their hands on fever-reducing drugs and antivirals such as Pfizer’s Paxlovid as infections across China outpace supplies.
They Created a Drug for Susannah. What About Millions of Other Patients?
Scientists have made rapid progress in customizing drugs for ultrarare diseases. The hard part now is making such treatments on a large scale.
Cold and Flu Medicine: What to Stock for the ‘Tripledemic’
Doctors weigh in on the essentials families need and what parents can do if they’re unable to find children’s pain reliever.
Can a Federally Funded ‘Netflix Model’ Fix the Broken Market for Antibiotics?
Shortages and drug-resistant germs have renewed attention on a $6 billion proposal in Congress that would reconfigure the way antimicrobial drugs are developed and sold.
Los bloqueadores de pubertad pueden ayudar a menores trans. ¿A qué costo?
Los bloqueadores de la pubertad pueden aliviar la angustia de los menores trans y ganar tiempo para sopesar las opciones. Pero las preocupaciones sobre los efectos físicos a largo plazo y otras consecuencias van en
As Covid Spreads Fast in China, Beijing Isn’t in Lockdown. But It Feels Like It.
Almost no one is venturing out even after an easing of pandemic measures. Cold and flu medicines are scarce, but food supplies appear adequate.
Countries Need to Make Their Own Vaccines. Why Isn’t the U.S. Embracing This Pandemic Prevention Strategy?
Every region of the world must be able to make its own vaccines.
Alzheimer’s APOE4 Genetic Risk Targeted in Promising Trial
Preliminary results offer hope that gene therapy can protect people with a version of the brain disease driven by a particular gene variant.
Alzheimer’s Drug May Benefit Some Patients, New Data Shows
The drug, lecanemab, made by Eisai and Biogen, also carried risks of brain swelling and bleeding and should be studied further, a report of the findings said.
Flu and R.S.V. Increase Demand for Antibiotics and Antivirals
An intense early flu season, coupled with a pediatric rise in respiratory illnesses, has left families frantically searching for medicines that are in short supply.
¿Qué es Ozempic y por qué genera tantos comentarios en internet?
Cada vez más personas recurren a este fármaco para la diabetes con el fin de inducir la pérdida de peso. Los expertos dicen que no es un medicamento milagroso.
How Immunocompromised Experts Will Celebrate Another Pandemic Holiday
Covid precautions have fallen by the wayside for many. But for the most vulnerable, risks are still front and center.
What Is Ozempic and Why Is It Getting So Much Attention?
More people are turning to a diabetes medication to induce weight loss — but experts say it’s not a miracle drug.
FDA Approves a Drug That Can Delay Type 1 Diabetes
The therapy will cost nearly $200,000. But it’s the first treatment in 100 years to alter the course of the disease, which usually begins in adolescence.
The End of Covid Vaccines at ‘Warp Speed’
Financial and bureaucratic barriers in the United States mean that the next generation of Covid vaccines may well be designed here, but used elsewhere.


